Cleared Special

K231653 - BASHIR™ .035 Endovascular Catheter, BASHIR™ S-B .035 Endovascular Catheter (FDA 510(k) Clearance)

Jul 2023
Decision
27d
Days
Class 2
Risk

K231653 is an FDA 510(k) clearance for the BASHIR™ .035 Endovascular Catheter, BASHIR™ S-B .035 Endovascular Catheter. This device is classified as a Mechanical Thrombolysis Catheter (Class II - Special Controls, product code QEY).

Submitted by Thrombolex, Inc. (New Britain, US). The FDA issued a Cleared decision on July 3, 2023, 27 days after receiving the submission on June 6, 2023.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.5150. To Mechanically Disrupt Thrombus And/or Debris In The Peripheral Vasculature..

Submission Details

510(k) Number K231653 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 06, 2023
Decision Date July 03, 2023
Days to Decision 27 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code QEY - Mechanical Thrombolysis Catheter
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.5150
Definition To Mechanically Disrupt Thrombus And/or Debris In The Peripheral Vasculature.